SciELO - Scientific Electronic Library Online

 
vol.91 número3Imported cutaneous leishmaniasis caused by Leishmania major in a Chinese laborer who worked in Saudi ArabiaTotal earlobe reconstruction with a superiorly based preauricular flap índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Anais Brasileiros de Dermatologia

versão impressa ISSN 0365-0596versão On-line ISSN 1806-4841

Resumo

MA, Han et al. Methotrexate and etanercept-induced primary cutaneous CD4 positive small/medium-sized pleomorphic T-cell lymphoma. An. Bras. Dermatol. [online]. 2016, vol.91, n.3, pp.368-371. ISSN 1806-4841.  https://doi.org/10.1590/abd1806-4841.20163875.

Immunosuppressive drugs and biological agents may represent a potential risk of lymphoma development in patients with rheumatoid arthritis. But most cases are diffuse, large B-cell lymphomas. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma, a provisional entity in the 2005 WHO-EORTC classification of cutaneous lymphomas, is only described in a limited number of reports. To our knowledge, our case is a rare instance of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma, after associated treatment with methotrexate and etanercept, in a patient with moderate rheumatoid arthritis who had undergone an orchidectomy incorrectly.

Palavras-chave : Biological agents; Lymphoma, T-Cell, peripheral; Lymphoma, T-Cell, cutaneous; Lymphoma, primary cutaneous anaplastic large cell; Methotrexate.

        · texto em Inglês     · Inglês ( pdf )